NCT02610088 Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide Status COMPLETED Phase PHASE4
NCT02609815 Initial Combination of Gemigliptin and Metformin on Microbiota Change Status COMPLETED Phase NA
NCT02608853 Estimation of Malignancy Rates Within Humedica Patient Populations Sampled to be Representative of Liraglutide Initiators and LEADER™ Trial Participants Status COMPLETED Phase N/A
NCT02607865 Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02607306 A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT02607007 The Effect of Dairy and Non-dairy Breakfasts on Satiety and Post-meal Glycemia in Healthy Older Adults Status COMPLETED Phase PHASE1/PHASE2
NCT02600377 A Series of Systematic Reviews and Meta-analyses of the Effect of Vegetarian/Vegan Diets on Cardiometabolic Risk Status UNKNOWN Phase N/A
NCT02600091 Mindfulness-based Cognitive Therapy to Improve Emotional Wellbeing and Glycaemic Control in Diabetes Status COMPLETED Phase NA
NCT02598986 Effect of Macronutrient Supplementation on Glycemic Index of Pita Bread Status COMPLETED Phase NA
NCT02597127 Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) Status COMPLETED Phase PHASE2
NCT02594033 A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles Status COMPLETED Phase PHASE1
NCT02590822 Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction Status RECRUITING Phase NA
NCT02589756 Fish or Nuts? Dietary Effects on Cardiometabolic Risk Factors and Persistent Organic Pollutants Status COMPLETED Phase NA
NCT02586519 Pressure-Sensing Insoles in the Neuropathic Ulcer Treatment Pathway Status TERMINATED Phase NA
NCT02582242 Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin Status COMPLETED Phase PHASE4